Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. CMP-001

   Regeneron UK Limited

   Melanoma

   phase 3 · small molecule · completed

   3 trials →

2. CO-338-087

   pharmaand GmbH

   Ovarian epithelial cancer, Malignant peritoneal neoplasm, advanced (FIGO stage III-IV), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer (who responded to front-line platinum-based chemotherapy), Fallopian tube cancer

   phase 3 · small molecule · active

   1 trial →

3. CO41685

   Hoffmann-La Roche

   Chronic Lymphocytic Leukemia (CLL)

   phase 3 · small molecule · active

   1 trial →

4. CO44657

   Hoffmann-La Roche

   Estrogen receptor (ER)-positive, HER2-negative advanced breast cancer

   phase 3 · small molecule · active

   1 trial →

5. CO45042

   Hoffmann-La Roche

   Previously Untreated Advanced or Metastatic Non-Squamous Non−Small Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

6. COLECALCIFEROL , PREDNISONE

   Fondazione Telethon ETS

   Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL)

   phase 3 · small molecule · active

   1 trial →

7. CORT125134-556

   CORCEPT THERAPEUTICS INC

   Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

   phase 3 · small molecule · active

   1 trial →

8. CP 751,871 (Figitumumab)

   Pfizer

   Carcinoma, Large Cell

   phase 3 · small molecule · terminated

   1 trial →

9. CPI-0610, CPI-0610

   Novartis Pharmaceuticals

   Myelofibrosis, Myeloproliferative Neoplasms (Myelofibrosis and Essential Thrombocythemia)

   phase 3 · small molecule · active

   1 trial →

10. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    High Risk Acute Myeloid Leukemia

    phase 3 · small molecule · completed

    1 trial →

11. CS1003-305

    Lacuna Pharma Pty Ltd

    Unresectable advanced hepatocellular carcinoma

    phase 3 · small molecule · active

    1 trial →

12. CSET 2021/3373

    The George Institute

    Patients with stage I, II, III hormone-receptor positive (HR+) breast cancer (BC) receiving adjuvant aromatase inhibitors (AI) and presenting AI-related musculoskeletal pain (reported average joint pain score of ≥ 4 out of 10 on the Brief Pain Inventory)

    phase 3 · small molecule · active

    1 trial →

13. CSET 2021/3373

    The George Institute

    Patients with stage I, II, III hormone-receptor positive (HR+) breast cancer (BC) receiving adjuvant aromatase inhibitors (AI) and presenting AI-related musculoskeletal pain (reported average joint pain score of ≥ 4 out of 10 on the Brief Pain Inventory)

    phase 3 · small molecule · active

    1 trial →

14. CSET 2025/4132

    The George Institute

    Acute Myeloid Leukemia, ONCOLOGY

    phase 3 · small molecule · active

    1 trial →

15. CSET N° 2023/3729

    The George Institute

    Synchronous oligometastatic non-small cell lung cancer (NSCLC)

    phase 3 · small molecule · active

    1 trial →

16. CT-P51 3.1

    Celltrion Healthcare Australia Pty Ltd

    Previously Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

17. CTRIAL-IE 12-01

    Ningbo Cancer Hospital

    Patients with 1-3 positive Nodes, Hormone Receptor-Positive and Her2-Negative Breast Cancer with recurrence Score (RS) of 25 or Less

    phase 3 · small molecule · active

    1 trial →

18. CTRIAL-IE 14-06

    Ningbo Cancer Hospital

    Metastatic Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

19. CTRIAL‐IE-22‐01

    Ningbo Cancer Hospital

    Early stage HER2-positive breast cancer

    phase 3 · small molecule · active

    1 trial →

20. CTX-009

    Compass Therapeutics

    Biliary Tract Cancer

    phase 3 · small molecule · active

    1 trial →

21. CWS-2007-HR

    Solid Biosciences

    Soft Tissue Sarcoma

    phase 3 · small molecule · completed

    1 trial →

22. Cabozantinib

    Takeda

    Metastatic Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

23. Calquence 100 mg hard capsules

    Lacuna Pharma Pty Ltd

    Relapsed or Refractory Chronic Lymphocytic Leukemia

    phase 3 · small molecule · active

    1 trial →

24. Calquence 100 mg hard capsules

    AstraZeneca AB

    Chronic lymphocytic leukemia

    phase 3 · small molecule · active

    1 trial →

25. Camrelizumab

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 · small molecule · active

    2 trials →

26. Capecitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 · small molecule · active

    1 trial →

27. Capecitabine

    Hoffmann-La Roche

    Gastric Cancer

    phase 3 · small molecule · terminated

    1 trial →

28. Capecitabine

    Pfizer

    Breast Neoplasms

    phase 3 · small molecule · terminated

    1 trial →

29. Capecitabine monotherapy

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 3 · small molecule · active

    1 trial →

30. Capecitabine(Aibin)

    The First People's Hospital of Lianyungang

    Stage III Esophageal Squamous Cell Carcinoma

    phase 3 · small molecule · active

    1 trial →

31. Capivasertib

    AstraZeneca

    Triple Negative Breast Neoplasms

    phase 3 · small molecule · active

    1 trial →

32. Capmatinib

    Novartis Pharmaceuticals

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · terminated

    1 trial →

33. Capox chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 3 · small molecule · active

    1 trial →

34. Carboplatin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 · small molecule · completed

    1 trial →

35. Carboplatin

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 · small molecule · active

    1 trial →

36. Carboplatin

    Alaunos Therapeutics

    Extensive-Stage Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

37. Carboplatin

    Hoffmann-La Roche

    Breast Neoplasms

    phase 3 · small molecule · completed

    1 trial →

38. Carrellizumab + Capecitabine

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Breast Neoplasms

    phase 3 · small molecule · active

    1 trial →

39. Casdatifan

    Arcus Biosciences

    Metastatic Clear Cell Renal Cell Carcinoma

    phase 3 · small molecule · active

    1 trial →

40. Casodex® Film-coated Tablets for Localised prostate cancer at hi…

    Ningbo Cancer Hospital

    Localised prostate cancer at high risk of recurrence

    phase 3 · small molecule · active

    1 trial →

41. Cediranib

    AstraZeneca

    Colorectal Cancer

    phase 3 · small molecule · completed

    1 trial →

42. Celecoxib

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

43. Cemiplimab

    Regeneron UK Limited

    Squamous Cell Carcinoma (SCC)

    phase 3 · small molecule · completed

    1 trial →

44. Cemiplimab

    Regeneron UK Limited

    Recurrent Lung Non-Small Cell Carcinoma

    phase 3 · mab · active

    1 trial →

45. Cemiplimab

    Regeneron UK Limited

    Cutaneous Squamous Cell Carcinoma (CSCC)

    phase 3 · small molecule · active

    1 trial →

46. Cemiplimab

    Regeneron UK Limited

    Cutaneous Squamous Cell Carcinoma

    phase 3 · small molecule · active

    7 trials →

47. Cetuximab

    Amgen

    Metastatic Colorectal Cancer

    phase 3 · small molecule · completed

    1 trial →

48. Chemotherapy

    International Peace Maternity and Child Health Hospital

    Non Small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

Frequently asked questions